Olympus reinforces advice over device issue linked to 113 serious injuries

The company received complaints that the ligation loop can become unintentionally anchored in place.

Medtronic launches insulin delivery system with Abbott-made sensor

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Akura Medical raises $53M to advance thrombectomy portfolio

Part of the money will go toward setting up a joint venture in Qatar, whose sovereign wealth fund led the round.

PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

Medtronic names Jeb Denny as chief medical officer for acute care and monitoring

Denny leads the unit after Medtronic combined its patient monitoring and respiratory businesses last year.

Richard Pazdur, FDA drug czar, to retire from agency

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating what’s already been a turbulent year at the FDA.

Cleveland Diagnostics wins FDA nod for prostate cancer test

The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.

FDA flags risk from dropped BD Alaris pumps after 2 injury reports

BD told customers to immediately remove from use any devices they drop or severely jar.

Building a better robot: How Virtual Incision plans to challenge Intuitive

Led by former Intuitive executive Jim Alecxih, Virtual Incision expects the miniaturized design of its robot to stand out in an increasingly crowded field of challengers.

CMS finalizes competitive bidding changes to diabetes devices

AdvaMed supported adjustments made from a draft version but still has concerns about the impact on patient access.

J&J’s US orthopedic leader leaves amid DePuy spinout process

Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.

CMS covers cardiac ablation in ambulatory surgery centers

Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

OIG report finds Medicare overpaying for CGMs and supplies

The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five years, the government watchdog said.

Lawmakers propose Medicare reimbursement pathway for AI devices

AdvaMed supports the legislation, which is intended to ensure AI-enabled devices receive an accurate CMS payment code.

Medtronic taps Jim Peichel as CTO

Peichel, who has worked at Medtronic for more than 25 years, succeeds Ken Washington, who retired earlier this month.

Abbott issues correction for millions of glucose sensors

The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

Insulet unveils plans for new diabetes devices

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 diabetes in 2028.

Ceribell wins FDA clearance for seizure-detection algorithm in neonates

By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 million market.

Okami raises $45M to commercialize vascular embolization devices

The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

Abbott’s $21B Exact Sciences buy reveals future strategy

The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing. 

GE HealthCare to buy Intelerad for $2.3B

GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal expands GE HealthCare’s presence in more outpatient settings.

Health tech venture capital investment rebounds in 2025: report

Funding through the third quarter surpassed last year’s total, according to PitchBook. Meanwhile, average deal sizes are skyrocketing as high valuations — especially for AI startups — drive larger rounds.

Solventum inks $725M Acera takeover

The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

Shockwave’s Nick West on shaking up treatment for blocked arteries

The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.

Abbott to acquire Exact Sciences for about $21B

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.

Updated Nov. 20, 2025